One more resident of Dubna SEZ launched the construction of its plant. PSK Pharma began to lay the foundation of the facility on the left-bank section of the special economic zone, as it completed the first concrete plate at the construction site of a pharmaceutical plant.
The pharmaceutical plant that will be built by PSK Pharma, a resident company, in Dubna SEZ of the Moscow region will be the only such sophisticated facility in Russia in terms of its equipment and innovative technologies. Its total surface area will be 9000 square meters, and the investments in the project will exceed a billion rubles. The resident plans to commission Stage 1 of the facility as early as by the end of this year and start the production of medicinal products in May 2018.
More details about this project were announced by Olga Turchaninova, Director of PSK Pharma LLC, at the official ceremony held to mark the start of works. She explained that the plant will manufacture vital and essential drugs and emphasized the exclusive nature of the future plant,
“The technologies that we will bring here by using the international experience are unique. We will set up here the manufacturing of a wide range of dosage forms intended for treatment of asthma and chronic obstructive pulmonary diseases. In addition, the plant will be the platform for the developing and mastering the biotechnology, which is a completely new area for Russia, and we are ready to do this.”